Brilliant Violet 510a,,cents anti-human CD8 [SK1] and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0476766
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $503.25
About this award
The University of Virginia awarded a contract to BioLegend Inc. on September 3, 2026, for the procurement of specialized laboratory reagents. The contract, identified as A207_PO-0476766, is valued at $503.00 and involves the delivery of flow cytometry antibodies to Shubha A Dighe at the University of Virginia in Virginia.
The deliverables consist of two distinct monoclonal antibody products: one unit of Brilliant Violet 510a conjugated anti-human CD8 [SK1] antibody priced at $185.25, and one unit of Brilliant Violet 711a conjugated anti-human CD19 [HIB19] antibody priced at $318.00. These reagents are fluorescently labeled immunological tools commonly utilized in cellular analysis and research applications within academic and clinical laboratory settings.
Line items
| Item | Total |
|---|---|
| Brilliant Violet 510a,,cents anti-human CD8 [SK1] | $185.25 |
| Brilliant Violet 711a,,cents anti-human CD19 [HIB19] | $318.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0476766?
Contract A207_PO-0476766 was awarded to BIOLEGEND INC. by University of Virginia on September 3, 2026.
How much is contract A207_PO-0476766 worth?
Its cumulative value is $503.25.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award